Illinois big man Tomislav Ivisic (ankle) and reserve guard Dra Gibbs-Lawhorn (illness) are questionable for Saturday's game against the Gophers according to the Big Ten's availability report.

In this video, I will go over Novo Nordisk's (NVO-3.62%) and Eli Lilly's recent earnings report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

That haul helped Novo’s total sales for 2024 grow 26% at constant currencies to 290.4 billion kroner (nearly $41 billion), contributing to operating profits of 128.3 billion kroner ($18 billion ...

Illinois Fighting Illini men's basketball head coach Brad Underwood revealed after Sunday's game that Illinois center Tomislav Ivisic played through the game at Michigan State with strep throat.

Novo Nordisk (NVO) announced Friday that its popular obesity therapy, semaglutide, marketed as Wegovy, led to 20.7% weight loss over 72 weeks at a higher dose of 7.2 mg in a late-stage trial ...

One of the changes Tomislav Ivisic returned to the starting lineup after missing three games and Dra Gibbs-Lawhorn got his first start with Kylan Boswell and Ben Humrichous coming off the bench ag ...

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this. On rare occasions, our expert team of analysts issues a “Double Down” stock ...

The typical observer of Sunday's Illinois-Michigan State matchup might have watched Illini sophomore center Tomislav Ivisic trying to find his place in the offense, struggling a bit with his shot ...

Bernard Arnault is once again in charge of Europe's most valuable company. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is rolling out new data on a higher-dose injection in obesity. In the phase 3b ...

Luxury fashion house LVMH has reclaimed its title as Europe’s most valuable company from Novo Nordisk, as early signs of a luxury comeback coincided with fresh struggles for the Danish Ozempic ...

Novo Nordisk reported strong data for its next-gen anti-obesity medicine. The Danish company has an excellent weight loss drug pipeline. But it's also diversifying its lineup and offering other ...